Stock Research for LIFE

LIFE

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LIFE Stock Chart & Research Data

The LIFE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LIFE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LIFE Due diligence Resources & Stock Charts

The LIFE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LIFE Detailed Price Forecast - CNN Money CNN View LIFE Detailed Summary - Google Finance
Yahoo View LIFE Detailed Summary - Yahoo! Finance Zacks View LIFE Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View LIFE Trends & Analysis - Trade-Ideas Barrons View LIFE Major Holders - Barrons
NASDAQ View LIFE Call Transcripts - NASDAQ Seeking View LIFE Breaking News & Analysis - Seeking Alpha
Spotlight View LIFE Annual Report - CompanySpotlight.com OTC Report View LIFE OTC Short Report - OTCShortReport.com
TradeKing View LIFE Fundamentals - TradeKing Charts View LIFE SEC Filings - Bar Chart
WSJ View Historical Prices for LIFE - The WSJ Morningstar View Performance/Total Return for LIFE - Morningstar
MarketWatch View the Analyst Estimates for LIFE - MarketWatch CNBC View the Earnings History for LIFE - CNBC
StockMarketWatch View the LIFE Earnings - StockMarketWatch MacroAxis View LIFE Buy or Sell Recommendations - MacroAxis
Bullish View the LIFE Bullish Patterns - American Bulls Short Pains View LIFE Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View LIFE Stock Mentions - StockTwits PennyStocks View LIFE Stock Mentions - PennyStockTweets
Twitter View LIFE Stock Mentions - Twitter Invest Hub View LIFE Investment Forum News - Investor Hub
Yahoo View LIFE Stock Mentions - Yahoo! Message Board Seeking Alpha View LIFE Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for LIFE - SECform4.com Insider Cow View Insider Transactions for LIFE - Insider Cow
CNBC View LIFE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LIFE - OTC Markets
Yahoo View Insider Transactions for LIFE - Yahoo! Finance NASDAQ View Institutional Holdings for LIFE - NASDAQ


Stock Charts

FinViz View LIFE Stock Insight & Charts - FinViz.com StockCharts View LIFE Investment Charts - StockCharts.com
BarChart View LIFE Stock Overview & Charts - BarChart Trading View View LIFE User Generated Charts - Trading View


Latest Financial News for LIFE

Edited Transcript of LIFE earnings conference call or presentation 19-Mar-18 9:00pm GMT
Posted on Friday June 08, 2018

Q4 2017 aTyr Pharma Inc Earnings Call


aTyr Pharma to Present at Jefferies 2018 Global Healthcare Conference
Posted on Thursday May 31, 2018

SAN DIEGO, May 31, 2018-- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that Sanjay ...


aTyr Pharma Presents Poster on Preclinical Data from ATYR1923 Program at American Thoracic Society 2018 International Conference
Posted on Thursday May 17, 2018

SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced a poster presentation at the American Thoracic Society (ATS) International Conference to be held from May 18 – 23, 2018 in San Diego, CA. The presentation discusses the preclinical characterization of ATYR1923 as an immuno-modulatory therapeutic candidate with potentially broad therapeutic application in interstitial lung diseases. “We are excited to present a thorough summary of our preclinical work from our ATYR1923 program, specifically as it relates to potential activity in interstitial lung diseases at the ATS International Conference in San Diego next week,” commented David King, Ph.D., Chief Scientific Officer of aTyr.


Edited Transcript of LIFE earnings conference call or presentation 14-May-18 12:00pm GMT
Posted on Tuesday May 15, 2018

Q1 2018 aTyr Pharma Inc Earnings Call


Enter a stock symbol to view the stock details.